Cargando…

Diagnostic and therapeutic value of progastrin‐releasing peptide on small‐cell lung cancer: A Single‐Center Experience in China

We aimed to compare the diagnostic efficiency of proGRP and NSE on SCLC and to investigate whether the change of proGRP level would predict therapeutic response. Patients who were firstly diagnosed pathologically in Nanjing Chest Hospital and measured proGRP level consecutively were enrolled in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xiao‐Yuan, Hu, Yang‐Bo, Li, Hui‐Juan, Wan, Bing, Zhang, Chen‐Xi, Zhang, Bin, Hu, Huan, Zhang, Qun, Lv, Tang‐Feng, Zhan, Ping, Song, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111817/ https://www.ncbi.nlm.nih.gov/pubmed/29989303 http://dx.doi.org/10.1111/jcmm.13722

Ejemplares similares

Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring
por: Barchiesi, Vittoria, et al.
Publicado: (2021)

Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients
por: Li, Li, et al.
Publicado: (2020)

Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy
por: Li, Ming, et al.
Publicado: (2020)

Instability of Plasma and Serum Progastrin-Releasing Peptide During Repeated Freezing and Thawing
por: Lee, Jae-Eun, et al.
Publicado: (2016)

Aptamer based surface plasma resonance assay for direct detection of neuron specific enolase and progastrin-releasing peptide (31-98)
por: Sun, Linlin, et al.
Publicado: (2021)

Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
por: TUTAR, Nuri, et al.
Publicado: (2019)

Targeting progastrin enhances radiosensitization of colorectal cancer cells
por: Kowalski-Chauvel, Aline, et al.
Publicado: (2017)

Prognostic Value of Plasma hPG(80) (Circulating Progastrin) in Metastatic Renal Cell Carcinoma
por: Kohli, Manish, et al.
Publicado: (2021)

Association between Serum Progastrin Biomarker Level and Gastric Cancer
por: Amjadi, Omolbanin, et al.
Publicado: (2022)

Acute effects of N‐terminal progastrin fragments on gastric acid secretion in man
por: Goetze, Jens P., et al.
Publicado: (2017)

Plasma progastrin‐releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis‐targeted agents in patients with metastatic castration‐resistant prostate cancer
por: Yashi, Masahiro, et al.
Publicado: (2022)

Progastrin Represses the Alternative Activation of Human Macrophages and Modulates Their Influence on Colon Cancer Epithelial Cells
por: Hernández, Carlos, et al.
Publicado: (2014)

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
por: You, Benoit, et al.
Publicado: (2019)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Dupuy, Marie, et al.
Publicado: (2022)

Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations
por: Dong, Juanjuan, et al.
Publicado: (2021)

Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor
por: Rurarz, Beata Paulina, et al.
Publicado: (2023)

Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma
por: Doucet, L., et al.
Publicado: (2023)

The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis
por: Jin, Guangchun, et al.
Publicado: (2017)

hPG(80) (circulating progastrin) as a blood biomarker for high-grade glial tumors: A pilot study
por: Casile, Melanie, et al.
Publicado: (2023)

Progastrin production transitions from Bmi1(+)/Prox1(+) to Lgr5(high) cells during early intestinal tumorigenesis
por: Giraud, J., et al.
Publicado: (2020)

The Diagnostic and Therapeutic Value of the Detection of Serum Amyloid A and C-Reactive Protein in Infants with Rotavirus Diarrhea
por: Lv, Yin-Jiang, et al.
Publicado: (2021)

Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
por: Prieur, Alexandre, et al.
Publicado: (2023)

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma
por: Miao, Qiang, et al.
Publicado: (2023)

hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors
por: Chauhan, Aman, et al.
Publicado: (2022)

Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer
por: Lv, Shui ping, et al.
Publicado: (2017)

Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer
por: Lu, Yi, et al.
Publicado: (2021)

Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutrophil Extracellular Traps in Patients With Gastric Adenocarcinoma
por: Zhang, Yiyin, et al.
Publicado: (2020)

Diagnostic Value of T-Cell Interferon-γ Release Assays on Cerebrospinal Fluid for Tuberculous Meningitis
por: Qin, Ling, et al.
Publicado: (2015)

Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer
por: Zhang, Wenjie, et al.
Publicado: (2022)

Diagnostic Value of Interferon-γ Release Assays on Pericardial Effusion for Diagnosis of Tuberculous Pericarditis
por: Bian, Sainan, et al.
Publicado: (2016)

Natriuretic peptides: Diagnostic and therapeutic use
por: Pandit, Kaushik, et al.
Publicado: (2011)

A Drug Carrier for Sustained Zero-Order Release of Peptide Therapeutics
por: Zhao, Ya-Nan, et al.
Publicado: (2017)

Diagnostic value of echocardiography in paracardiac cystic lesions: 43 cases from one single medical center
por: Liu, Jinfeng, et al.
Publicado: (2021)

An aptamer-based depot system for sustained release of small molecule therapeutics
por: Wang, Dali, et al.
Publicado: (2023)

Prognostic Value of Adrenomedullin and Natriuretic Peptides in Uroseptic Patients Induced by Ureteroscopy
por: Hu, Wei, et al.
Publicado: (2016)

Diagnostic value of medical thoracoscopy in malignant pleural effusion
por: Wu, Yan-Bing, et al.
Publicado: (2017)

A summary of the current diagnostic methods for, and exploration of the value of microRNAs as biomarkers in, sepsis-associated encephalopathy
por: Yuechen, Zhang, et al.
Publicado: (2023)

Diagnostic and therapeutic value of biomarkers in urosepsis
por: Wu, Yuyun, et al.
Publicado: (2023)

The diagnostic value of the ultrasound gray scale ratio for different sizes of thyroid nodules
por: Chen, Xiaoyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_krogel6b8og3ir3p4hu1792g5a